Expert Analysis

Treatment Issues in Resource-Limited Settings

Source: CCO Official Conference Coverage of the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention

Treatment Issues in Resource-Limited Settings

Faculty:

Richard E. Chaisson, MD
Hoosen Coovadia, MBBS, MD, FCP
Mauro Schechter, MD, PhD

CREDIT INFORMATION

Release Date: 10/01/07

Expiration Date: 09/30/08

Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Registered Nurses: 1.2 Nursing contact hours

Pharmacists: 1.2 contact hours (0.12 CEUs)

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Explain the results of recent clinical studies on mother-to-child transmission of HIV during breast-feeding
Describe new insights into the early treatment of HIV infection in children
Discuss the latest findings regarding the clinical management of tuberculosis in HIV-infected patients in developing countries

Topics covered include:

The MITRA PLUS Study: Prevention of MTCT With the Use of HAART During Late Pregnancy and Breast-feeding
The AMATA Study: Impact of Breast-feeding Plus Maternal HAART vs Formula Feeding on MTCT
ZEBS: Exclusive Breast-feeding Associated With Reduced Risk of MTCT During First 4 Months of Infancy
Formula Feeding and MTCT of HIV in Kenya
Impact of Exposure to HIV on Infant Growth and Development in Ugandan Population
CHER Study: Early Initiation of Antiretroviral Therapy in HIV-Infected Infants
Importance of Virologic Monitoring in Resource-Limited Settings
Increased Mortality in HIV-Infected Individuals due to Cardiovascular Disease and Diabetes Among a Brazilian Population
Nevirapine-Based Therapy Among HIV/TB-Coinfected Patients

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.